Clinical Trials
3 trialsNCT04887194 2024-05-08
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Mirati Therapeutics Inc.
Phase 1 Completed
NCT02094625 2023-04-18
NAC to Prevent Cisplatin-induced Hearing Loss
Children's Hospital Los Angeles
Phase 1 Completed
NCT02908750 2022-11-14
Study to Assess the Effect of Osimertinib (TAGRISSOâ„¢ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed